{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:07:52Z","timestamp":1791317272604,"version":"4.3.1"},"reference-count":71,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jcrsjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.jcrs.2016.06.006","type":"journal-article","created":{"date-parts":[[2016,10,2]],"date-time":"2016-10-02T22:55:04Z","timestamp":1475448904000},"page":"1368-1379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":90,"title":["Cataract surgery and nonsteroidal antiinflammatory drugs"],"prefix":"10.1097","volume":"42","author":[{"given":"Richard S.","family":"Hoffman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Braga-Mele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kendall","family":"Donaldson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Emerick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malik","family":"Kahook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Mamalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin M.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Realini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal H.","family":"Shorstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard K.","family":"Stiverson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Wirostko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-18-20210210","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.2165\/00003495-200767090-00004","article-title":"The role of NSAIDs in the management of postoperative ophthalmic inflammation.","volume":"67","author":"Colin","year":"2007","journal-title":"Drugs"},{"key":"R3-18-20210210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00004397-200201000-00003","article-title":"Topical nonsteroidal anti-inflammatory drugs in ophthalmology.","volume":"42","author":"Flach","year":"2002","journal-title":"Int Ophthalmol Clin"},{"key":"R4-18-20210210","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000068563","article-title":"Topical nonsteroidal anti-inflammatory therapy in ophthalmology.","volume":"217","author":"Schalnus","year":"2003","journal-title":"Ophthalmologica"},{"key":"R5-18-20210210","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0378-5173(89)90047-1","article-title":"Transport mechanisms of the cornea: characterization of barrier permselectivity.","volume":"55","author":"Rojanasakul","year":"1989","journal-title":"Int J Pharm"},{"key":"R6-18-20210210","first-page":"844","article-title":"Effect of concentration, pH and preservatives on in vitro transcorneal permeation of ibuprofen and flurbiprofen from non-buffered aqueous drops.","volume":"35","author":"Gupta","year":"1997","journal-title":"Indian J Exp Biol"},{"key":"R8-18-20210210","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1021\/jm00377a001","article-title":"Anti-inflammatory agents. 3. Synthesis and pharmacological evaluation of 2-amino-3-benzoylphenylacetic acid and analogues.","volume":"27","author":"Walsh","year":"1984","journal-title":"J Med Chem"},{"key":"R9-18-20210210","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1089\/jop.2007.0040","article-title":"The systemic safety of bromfenac ophthalmic solution 0.09.","volume":"23","author":"Stewart","year":"2007","journal-title":"J Ocul Pharmacol Ther"},{"key":"R11-18-20210210","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1185\/030079906X112471","article-title":"Comparison of cyclooxygenase inhibitory activity and ocular anti-inflammatory effects of ketorolac tromethamine and bromfenac sodium.","volume":"22","author":"Waterbury","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"R12-18-20210210","first-page":"406","article-title":"Effects of bromfenac sodium, non-steroidal anti-inflammatory drug, on acute ocular inflammation Japanese Nippon Ganka Gakkai Z","volume":"99","author":"Ogawa","year":"1995","journal-title":"asshi"},{"key":"R16-18-20210210","first-page":"941","article-title":"In vitro transcorneal permeation of ketorolac tromethamine from buffered and non-buffered aqueous ocular drops.","volume":"35","author":"Malhotra","year":"1997","journal-title":"Indian J Exp Biol"},{"key":"R17-18-20210210","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/0272-0590(89)90043-2","article-title":"An objective procedure for quantitating eye irritation based upon changes of corneal thickness.","volume":"12","author":"Kennah","year":"1989","journal-title":"Fundam Appl Toxicol"},{"key":"R18-18-20210210","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1023\/A:1007049015148","article-title":"Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: I. Assessment of anti-inflammatory efficacy.","volume":"24","author":"Gamache","year":"2000","journal-title":"Inflammation"},{"key":"R19-18-20210210","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1023\/A:1007001131987","article-title":"Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: II. In vitro bioactivation and permeation of external ocular barriers.","volume":"24","author":"Ke","year":"2000","journal-title":"Inflammation"},{"key":"R20-18-20210210","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1023\/A:1026024409826","article-title":"Inflammation-mediated retinal edema in the rabbit is inhibited by topical nepafenac.","volume":"27","author":"Kapin","year":"2003","journal-title":"Inflammation"},{"key":"R21-18-20210210","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.survophthal.2009.07.005","article-title":"Nonsteroidal anti-inflammatory drugs in ophthalmology.","volume":"55","author":"Kim","year":"2010","journal-title":"Surv Ophthalmol"},{"key":"R24-18-20210210","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1442-9071.1985.tb00415.x","article-title":"Pathophysiology and pharmacology of intraocular surgery.","volume":"13","author":"Mishima","year":"1985","journal-title":"Aust N Z J Ophthalmol"},{"key":"R25-18-20210210","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/ICU.0000000000000116","article-title":"Small pupil and cataract surgery.","volume":"26","author":"Hashemi","year":"2015","journal-title":"Curr Opin Ophthalmol"},{"key":"R27-18-20210210","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.jcrs.2007.05.013","article-title":"Clinical pseudophakic cystoid macular edema; risk factors for development and duration after treatment.","volume":"33","author":"Henderson","year":"2007","journal-title":"J Cataract Refract Surg"},{"key":"R28-18-20210210","first-page":"581","article-title":"Tissue culture of human lens epithelial cells.","volume":"95","author":"Nishi","year":"1991","journal-title":"Part II: Suppressive effect of diclofenac sodium on their proliferation and metaplasia Japanese Nippon Ganka Gakki Zasshi"},{"key":"R30-18-20210210","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/S0161-6420(94)31209-7","article-title":"Variation in cataract surgery practice and clinical outcomes.","volume":"101","author":"Schein","year":"1994","journal-title":"Ophthalmology"},{"key":"R31-18-20210210","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0161-6420(99)00184-0","article-title":"Initial two years of experience with the AAO National Eyecare Outcomes Network (NEON) cataract surgery database.","volume":"107","author":"Lum","year":"2000","journal-title":"Ophthalmology"},{"key":"R34-18-20210210","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ophtha.2010.07.023","article-title":"Prevalence and predictors of ocular complications associated with cataract surgery in United States veterans.","volume":"118","author":"Greenberg","year":"2011","journal-title":"Ophthalmology"},{"key":"R35-18-20210210","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.ophtha.2010.11.001","article-title":"Whole population trends in complications of cataract surgery over 22 years in Western Australia.","volume":"118","author":"Clark","year":"2011","journal-title":"Ophthalmology"},{"key":"R36-18-20210210","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1016\/j.jcrs.2012.07.029","article-title":"Incidence of acute postoperative cystoid macular edema in clinical practice.","volume":"38","author":"Packer","year":"2012","journal-title":"J Cataract Refract Surg"},{"key":"R38-18-20210210","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/j.jcrs.2006.04.009","article-title":"Preoperative ketorolac tromethamine 0.4 in phacoemulsification outcomes: Pharmacokinetic-response curve.","volume":"32","author":"Donnenfeld","year":"2006","journal-title":"J Cataract Refract Surg"},{"key":"R39-18-20210210","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.jcrs.2007.01.033","article-title":"Preoperative topical indomethacin to prevent pseudophakic cystoid macular edema.","volume":"33","author":"Yavas","year":"2007","journal-title":"J Cataract Refract Surg"},{"key":"R40-18-20210210","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0021-5155(99)00176-8","article-title":"Comparison of diclofenac and fluorometholone in preventing cystoid macular edema after small incision cataract surgery: a multicentered prospective trial.","volume":"44","author":"Miyake","year":"2000","journal-title":"Jpn J Ophthalmol"},{"key":"R42-18-20210210","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jcrs.2007.08.030","article-title":"Reducing angiographic cystoid macular edema and blood-aqueous barrier disruption after small-incision phacoemulsification and foldable intraocular lens implantation; multicenter prospective randomized comparison of topical diclofenac 0.1 and betamethasone 0.1.","volume":"34","author":"Asano","year":"2008","journal-title":"J Cataract Refract Surg"},{"key":"R43-18-20210210","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.jcrs.2011.03.052","article-title":"Nepafenac 0.1 verus fluorometholone 0.1 for preventing cystoid macular edema after cataract surgery.","volume":"37","author":"Miyake","year":"2011","journal-title":"J Cataract Refract Surg"},{"key":"R45-18-20210210","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000346847","article-title":"Q-w, Yao K, Xu W, Chen P-q, Shentu X-c, Xie X, Weng Y, Zhang L, Jin C-f, Wu W, Zhu Y-n, Yu Y-h. Bromfenac sodium 0.1, fluorometholone 0.1 and dexamethasone 0.1 for control of ocular inflammation and prevention of cystoid macular edema after phacoemulsification.","volume":"229","year":"2013","journal-title":"Ophthalmologica"},{"key":"R46-18-20210210","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.ajo.2015.07.032","article-title":"Prevention of cystoid macular edema after cataract surgery in nondiabetic and diabetic patients: A systematic review and meta-analysis.","volume":"160","author":"Wielders","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"R47-18-20210210","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.jcrs.2013.12.023","article-title":"Nepafenac 0.1 plus dexamethasone 0.1 versus dexamethasone alone: effect on macular swelling after cataract surgery.","volume":"40","author":"Zaczek","year":"2014","journal-title":"J Cataract Refract Surg"},{"key":"R48-18-20210210","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ajo.2008.04.036","article-title":", on behalf of the Acular LS for Cystoid Macular Edema (ACME) Study Group. A randomized, masked comparison of topical ketorolac 0.4 plus steroid vs steroid alone in low-risk cataract surgery patients.","volume":"146","author":"Wittpenn","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"R49-18-20210210","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1016\/j.ophtha.2015.08.024","article-title":"Comparative effectiveness of three prophylactic strategies to prevent clinical macular edema following phacoemulsification surgery.","volume":"122","author":"Shorstein","year":"2015","journal-title":"Ophthalmology"},{"key":"R51-18-20210210","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.jcrs.2013.09.018","article-title":"Improving visual outcomes by preserving outer retina morphology in eyes with resolved pseudophakic cystoids macular edema.","volume":"40","author":"Hunter","year":"2014","journal-title":"J Cataract Refract Surg"},{"key":"R52-18-20210210","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0161-6420(85)33966-0","article-title":"Pharmacologic therapy of aphakic and pseudophakic cystoid macular edema; 1985 Update.","volume":"92","author":"Jampol","year":"1985","journal-title":"Ophthalmology"},{"key":"R55-18-20210210","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/IAE.0b013e3181fd9740","article-title":"Pharmacologic therapy of pseudophakic cystoid macular edema; 2010 update.","volume":"31","author":"Shelsta","year":"2011","journal-title":"Retina"},{"key":"R56-18-20210210","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0002-9394(79)90235-6","article-title":"The effect of indomethacin pretreatment on aphakic cystoids macular edema.","volume":"87","author":"Klein","year":"1979","journal-title":"Am J Ophthalmol"},{"key":"R57-18-20210210","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/IAE.0b013e3181bdfa43","article-title":"Pilot study of intravitreal injection of diclofenac for treatment of macular edema of various etiologies.","volume":"30","author":"Soheilian","year":"2010","journal-title":"Retina"},{"key":"R58-18-20210210","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/IAE.0b013e3181b8628e","article-title":"NSAIDs in combination therapy for the treatment of chronic pseudophakic cystoid macular edema.","volume":"30","author":"Warren","year":"2010","journal-title":"Retina"},{"key":"R59-18-20210210","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/S0886-3350(02)01334-2","article-title":"Latanoprost and clinically significant cystoid macular edema after uneventful phacoemulsification with intraocular lens implantation.","volume":"28","author":"Yeh","year":"2002","journal-title":"J Cataract Refract Surg"},{"key":"R61-18-20210210","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S0886-3350(00)00706-9","article-title":"Intraindividual comparison of the effects of a fixed dorzolamide-timolol combination and latanoprost on intraocular pressure after small incision cataract surgery.","volume":"27","author":"Rainer","year":"2001","journal-title":"J Cataract Refract Surg"},{"key":"R63-18-20210210","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/archopht.1987.01060060051031","article-title":"Extracapsular cataract extraction with posterior chamber lens implantation in patients with glaucoma.","volume":"105","author":"Handa","year":"1987","journal-title":"Arch Ophthalmol"},{"key":"R64-18-20210210","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/IJG.0b013e3181a98b97","article-title":"Clinical cystoid macular edema after cataract surgery in glaucoma patients.","volume":"19","author":"Law","year":"2010","journal-title":"J Glaucoma"},{"key":"R65-18-20210210","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/IJG.0b013e318237bf9e","article-title":"Postoperative treatment with topical diclofenac versus topical dexamethasone after combined phacotrabeculectomy with mitomycin C.","volume":"22","author":"Levkovitch-Verbin","year":"2013","journal-title":"J Glaucoma"},{"key":"R66-18-20210210","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/00061198-199400320-00018","article-title":"Exfoliation syndromethe most common identifiable cause of open-angle glaucoma.","volume":"3","author":"Ritch","year":"1994","journal-title":"J Glaucoma"},{"key":"R67-18-20210210","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0886-3350(02)01993-4","article-title":"Outcomes of phacoemulsification in patients with and without pseudoexfoliation syndrome.","volume":"29","author":"Shingleton","year":"2003","journal-title":"J Cataract Refract Surg"},{"key":"R68-18-20210210","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0886-3350(97)80162-9","article-title":"Exfoliation syndrome and phacoemulsification.","volume":"23","author":"Dosso","year":"1997","journal-title":"J Cataract Refract Surg"},{"key":"R69-18-20210210","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S0886-3350(00)00691-X","article-title":"Intraocular pressure after phacoemulsification and intraocular lens implantation in non-glaucomatous eyes with and without pseudoexfoliation.","volume":"27","author":"Pohjalainen","year":"2001","journal-title":"J Cataract Refract Surg"},{"key":"R70-18-20210210","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ophtha.2007.03.058","article-title":"Intraocular pressure elevation within the first 24 hours after cataract surgery in patients with glaucoma or exfoliation syndrome.","volume":"115","author":"Levkovitch-Verbin","year":"2008","journal-title":"Ophthalmology"},{"key":"R71-18-20210210","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.jcrs.2009.03.011","article-title":"Pseudoexfoliation and the cataract surgeon: preoperative, intraoperative, and postoperative issues related to intraocular pressure, cataract, and intraocular lenses.","volume":"35","author":"Shingleton","year":"2009","journal-title":"J Cataract Refract Surg"},{"key":"R73-18-20210210","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/S0886-3350(01)00960-9","article-title":"Phacoemulsification in Indian eyes with pseudoexfoliation syndrome.","volume":"27","author":"Shastri","year":"2001","journal-title":"J Cataract Refract Surg"},{"key":"R74-18-20210210","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/S0886-3350(99)00196-0","article-title":"Cystoid macular edema after phacoemulsification: relationship to blood-aqueous barrier damage and visual acuity.","volume":"25","author":"Ursell","year":"1999","journal-title":"J Cataract Refract Surg"},{"key":"R75-18-20210210","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3129\/i06-062","article-title":"Cystoid macular edema after phacoemulsification: risk factors and effect on visual acuity.","volume":"41","author":"Gulkilik","year":"2006","journal-title":"Can J Ophthalmol"},{"key":"R78-18-20210210","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/01.iae.0000249577.92800.c0","article-title":"Evaluation of costs for cystoid macular edema among patients after cataract surgery.","volume":"27","author":"Schmier","year":"2007","journal-title":"Retina"},{"key":"R79-18-20210210","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ajo.2009.02.029","article-title":"Incidence of cystoid macular edema after cataract surgery in patients with and without uveitis using optical coherence tomography.","volume":"148","author":"Belair","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"R80-18-20210210","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/ICB.0b013e31825a300f","article-title":"Topical steroids and nonsteroidal antiinflammatory drugs for the treatment of cystoid macular edema in retinitis pigmentosa.","volume":"7","author":"Park","year":"2013","journal-title":"Retin Cases Brief Rep"},{"key":"R82-18-20210210","doi-asserted-by":"crossref","first-page":"337","DOI":"10.7326\/0003-4819-111-4-337","article-title":"Acute asthma attack due to ophthalmic indomethacin.","volume":"111","author":"Sheehan","year":"1989","journal-title":"Ann Intern Med"},{"key":"R83-18-20210210","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0161-6420(96)30591-5","article-title":"Asthma caused by topical application of ketorolac.","volume":"103","author":"Sitenga","year":"1996","journal-title":"Ophthalmology"},{"key":"R84-18-20210210","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0039-6257(92)90095-B","article-title":"Cyclo-oxygenase inibitors in ophthalmology.","volume":"36","author":"Flach","year":"1992","journal-title":"Surv Ophthalmol"},{"key":"R85-18-20210210","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2165\/00002018-200225040-00002","article-title":"Topical nonsteroidal anti-inflammatory drugs for ophthalmic use; a safety review.","volume":"25","author":"Gaynes","year":"2002","journal-title":"Drug Saf"},{"key":"R89-18-20210210","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/00003226-199511000-00018","article-title":"Persistent epithelial defect following penetrating keratoplasty: an adverse effect of diclofenac eyedrops.","volume":"14","author":"Shimazaki","year":"1995","journal-title":"Cornea"},{"key":"R92-18-20210210","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0161-6420(01)00930-7","article-title":"Possible role of the vitamin E solubilizer in topical diclofenac on matrix metalloproteinase expression in corneal melting; an analysis of postoperative keratolysis.","volume":"109","author":"Hargrave","year":"2002","journal-title":"Ophthalmology"},{"key":"R93-18-20210210","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/01.ico.0000177835.93130.d4","article-title":"Three cases of corneal melting after instillation of a new nonsteroidal anti-inflammatory drug.","volume":"25","author":"Asai","year":"2006","journal-title":"Cornea"},{"key":"R94-18-20210210","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1097\/ICO.0b013e3180cfe626","article-title":"Case of corneal melting associated with the use of topical nepafenac.","volume":"26","author":"Bekendam","year":"2007","journal-title":"Cornea"},{"key":"R95-18-20210210","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S0886-3350(01)00801-X","article-title":"Corneal complications associated with topical ophthalmic use of nonsteroidal antiinflammatory drugs.","volume":"27","author":"Congdon","year":"2001","journal-title":"J Cataract Refract Surg"},{"key":"R96-18-20210210","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/ICL.0b013e31814510a8","article-title":"Corneal melting after use of nepafenac in a patient with chronic cystoid macular edema after cataract surgery.","volume":"34","author":"Di Pascuale","year":"2008","journal-title":"Eye Contact Lens"},{"key":"R97-18-20210210","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0161-6420(00)00538-8","article-title":"Keratitis, ulceration, and perforation associated with topical nonsteroidal anti-inflammatory drugs.","volume":"108","author":"Guidera","year":"2001","journal-title":"Ophthalmology"},{"key":"R98-18-20210210","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.jcrs.2007.04.041","article-title":"Corneal melting and perforation in Stevens Johnson syndrome following topical bromfenac use.","volume":"33","author":"Isawi","year":"2007","journal-title":"J Cataract Refract Surg"},{"key":"R99-18-20210210","first-page":"1129","article-title":"Corneal melting associated with use of topical nonsteroidal anti-inflammatory drugs after ocular surgery.","volume":"118","author":"Lin","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"R100-18-20210210","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.jcrs.2007.06.043","article-title":"Nepafenac-associated corneal melt.","volume":"33","author":"Wolf","year":"2007","journal-title":"J Cataract Refract Surg"}],"container-title":["Journal of Cataract and Refractive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088633501630178X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088633501630178X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/10.1016\/j.jcrs.2016.06.006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T18:26:44Z","timestamp":1623781604000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/02158034-201609000-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":71,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1016\/j.jcrs.2016.06.006","relation":{},"ISSN":["0886-3350"],"issn-type":[{"value":"0886-3350","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cataract surgery and nonsteroidal antiinflammatory drugs","name":"articletitle","label":"Article Title"},{"value":"Journal of Cataract & Refractive Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcrs.2016.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 ASCRS and ESCRS Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}